Concord Biotech Ltd (CONB)

BSE
Currency in INR
1,657.85
-31.95(-1.89%)
Closed
CONB Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
1,643.901,694.40
52 wk Range
1,326.902,658.00
Key Statistics
Edit
Bid/Ask
1,652.25 / 1,657.85
Prev. Close
1,689.8
Open
1,689.9
Day's Range
1,643.9-1,694.4
52 wk Range
1,326.9-2,658
Volume
3K
Average Volume (3m)
7.96K
1-Year Change
13.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CONB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
No news in this category
Looks like there are no results in this news category

Concord Biotech Ltd Company Profile

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

Employees
1377
Market
India

Compare CONB to Peers and Sector

Metrics to compare
CONB
Peers
Sector
Relationship
P/E Ratio
53.8x30.5x−0.5x
PEG Ratio
7.630.300.00
Price/Book
11.0x4.1x2.6x
Price / LTM Sales
16.1x4.5x3.0x
Upside (Analyst Target)
11.4%14.6%55.6%
Fair Value Upside
Unlock−0.2%10.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 31.19%
Dividend Yield
0.52%
Industry Median 0.71%
Annualised payout
8.75
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 13, 2025
EPS / Forecast
7.30 / 8.90
Revenue / Forecast
2.44B / 2.44B
EPS Revisions
Last 90 days

FAQ

What Is the Concord Biotech (CONB) Stock Price Today?

The Concord Biotech stock price today is 1,657.85.

What Stock Exchange Does Concord Biotech Trade On?

Concord Biotech is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Concord Biotech?

The stock symbol for Concord Biotech is "CONB."

Does Concord Biotech Pay Dividends? What’s The Current Dividend Yield?

The Concord Biotech Ltd dividend yield is 0.52%.

What Is the Concord Biotech Market Cap?

As of today, Concord Biotech market cap is 176.86B.

What is Concord Biotech Earnings Per Share?

The Concord Biotech EPS is 31.19.

What Is the Next Concord Biotech Earnings Date?

Concord Biotech will release its next earnings report on 21 May 2025.

From a Technical Analysis Perspective, Is CONB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.